Mental Health Services
Conditions
Keywords
Mental disorders, Quality of life, Drug-related problems
Brief summary
This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL) The hypothesis of the study are: 1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care, 2. Treatment effectiveness and safety affect the subjects´ QoL
Detailed description
The study objectives are to: 1. assess QoL in subjects using psycholeptics and psychoanaleptics, 2. analyze identified DRPs and their causes in subjects using psycholeptics and psychoanaleptics 3. evaluate the correlation between the type and total number of DRPs identified in a single subject with QoL, 4. describe the impact of pharmacists´ intervention in the identification and resolution of the DRPs and their causes on subjects´ QoL.
Interventions
OTHERPharmaceutical care in solving drug-related problems in subjects using psychotropic medicines based on standardized protocol..
Pharmacists' interventions were based on Medication Review and Medication Therapy Management evaluations of a subjects' pharmacotherapy to optimize medicine use, improve treatment outcomes and quality of life. The intervention involved the identification of drug-related problems and addressing these issues through pharmacist interventions. The intervention was based on information gathered from the subjects and a list of medicines in use.
OTHERCommon pharmacists' practice in Croatia.
Group B participants received pharmaceutical care based on common pharmacists' practice in Croatia during the dispensing of psychotropic drugs.
Sponsors
University of Rijeka
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult participants (years 18+) * Usage of psycholeptic or psychoanaleptic medicines * Residence in Istrian County (Croatia)
Exclusion criteria
* Minor participants * Hospitalization during study participation * Unable to live by themselves * Unable to participate in study for 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of the quality of life in subjects using psycholeptics and psychoanaleptics | Prior and after the pharmacists' intervention during three months period. | A short version of the World Health Organization's quality of life questionnaire (WHOQOL-BREF questionnaire) is being used to assess subjects' QoL. The scale range is from 0 to 100. A higher score number indicates better QoL. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Analysis of identified drug-related problems | During period of three months. | To analyze the type of DRPs, validated Classification for Drug-Related Problems from the Pharmaceutical Care Network Europe Association, version 9.1 has been used. PCNE Classification for DRPs describes each type of DRP by unique code. |
Countries
Croatia
Outcome results
None listed